Marché mondial de la chimie médicinale pour la découverte de médicaments – Tendances et prévisions de l’industrie jusqu’en 2030

Analyse et taille du marché de la chimie médicinale pour la découverte de médicaments

Les principaux facteurs qui stimulent le marché de la chimie médicinale pour la découverte de médicaments sont l'augmentation des applications dans le diagnostic clinique et la demande croissante de diagnostic de maladies rares. La chimie médicinale pour la découverte de médicaments comprend des caractéristiques telles que le besoin croissant de médicaments sûrs et efficaces qui aura un impact sur le lancement de nouveaux produits par les fabricants sur le marché, ce qui augmentera sa demande ainsi que l'augmentation des investissements en recherche et développement pour la découverte et le développement de nouvelles molécules médicamenteuses conduisant à la croissance du marché. Actuellement, diverses études de recherche sont en cours qui devraient offrir diverses autres opportunités sur le marché de la chimie médicinale pour la découverte de médicaments. Le développement de techniques de laboratoire avancées, d'outils informatiques et d'intelligence artificielle pour la découverte de médicaments accélère le processus et augmente les chances de succès. De plus, les progrès de la biotechnologie, de la génomique et de la protéomique ont permis une meilleure compréhension des mécanismes des maladies. Ces connaissances sont cruciales pour concevoir des médicaments avec une plus grande spécificité et efficacité. Cela, à son tour, étendra les opportunités rentables pour les acteurs du marché au cours de la période de prévision de 2023 à 2030 en permettant un séquençage plus complet et plus rentable.

En outre, l'adoption croissante de la médecine personnalisée devrait également offrir des opportunités potentielles de croissance du marché de la chimie médicinale pour la découverte de médicaments au cours de la période de prévision. Cependant, les risques techniques liés à la découverte de médicaments et le manque de professionnels qualifiés devraient freiner la croissance du marché au cours de la période de prévision.

Data Bridge Market Research analyse que le marché mondial de la chimie médicinale pour la découverte de médicaments, qui était de 5 379,22 millions USD en 2022, devrait atteindre 14 306,98 millions USD d'ici 2030 et devrait connaître un TCAC de 13,60 % au cours de la période de prévision. Les « hôpitaux et cliniques » dominent le segment des utilisateurs finaux du marché de la chimie médicinale pour la découverte de médicaments en raison de la demande croissante de produits. En plus des informations sur les scénarios de marché tels que la valeur marchande, le taux de croissance, la segmentation, la couverture géographique et les principaux acteurs, les rapports de marché organisés par Data Bridge Market Research comprennent également une analyse approfondie des experts, l'épidémiologie des patients, l'analyse du pipeline, l'analyse des prix et le cadre réglementaire.

Portée du rapport et segmentation du marché

Définition du marché

Medicinal chemistry is the interdisciplinary field of science that involves a team of scientists (including synthetic organic chemists, analytical chemists, biologists, toxicologists, pharmacologists, microbiologists, and biopharmacists) working together for drug discovery, design, development and synthesis of new pharmaceuticals. Moreover, the contribution of medicinal chemistry is not confined just to the discovery stage. It carries its purpose along the entire spectrum of clinical development. Each and every stage of clinical development involves surplus amounts of formulated drugs for studying potential benefits in human trials. With time the chemical methods adopted for the discovery of the molecules have also undergone changes leading to the development of technologies such as combinatorial chemistry (combichem), microwave assisted organic synthesis (MAOS) and high-throughput (HTS) biological screening.

Global Medicinal Chemistry for Drug Discovery Market Dynamics

Drivers

• Increasing  disease burden

The most major element driving this market's growth is the rising prevalence of various diseases, including cancer, cardiovascular diseases, and infectious diseases, drives the need for new and more effective drugs. Medicinal chemistry plays a critical role in drug discovery for these conditions which is expected to drive the market in the forecast period

• Rising number of geriatric population

The global aging population increases the demand for pharmaceuticals. Elderly individuals often require medications for chronic diseases and age-related conditions, leading to a need for innovative drug discovery. The increasing geriatric population is associated with a higher prevalence of these conditions, leading to increased demand for drug discovery. Thus, expanding geriatric population worldwide is predicted to favour the market

• Rising healthcare expenditure

Increasing healthcare spending by governments and individuals can support drug discovery efforts and drive market growth. Moreover, investment from governments, private organizations, and pharmaceutical companies in research and development (R&D) for drug discovery can drive advancements in medicinal chemistry.

Opportunities

• Technological advancement of therapies for the treatment

The development of advanced laboratory techniques, computational tools, and artificial intelligence for drug discovery accelerates the process and increases the likelihood of success. Moreover, advancements in biotechnology, genomics, and proteomics has enabled a better understanding of disease mechanisms. This knowledge is crucial for designing drugs with greater specificity and effectiveness. This, in turn, will extend profitable opportunities for the market players in the forecast period of 2023 to 2030 by enabling more comprehensive and cost-effective sequencing.

Restraints/Challenges

• High cost of research

On the other hand, the high Development cost of research, clinical trials, and regulatory compliance can be a significant restraint, particularly for smaller pharmaceutical companies and startups which is further projected to impede the growth of the medicinal chemistry for drug discovery market in the targeted period. Moreover, technical risks in drug discovery and lack of trained skilled professionals expected to further challenge the growth of the medicinal chemistry for drug discovery market.

This medicinal chemistry for drug discovery market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the medicinal chemistry for drug discovery market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Development

• In November 2021, Jubilant Biosys Limited expanded its facilities in order to support the drug discovery chemistry services and in-vitro ADME services. Moreover, the company is providing services for Turning Point Therapeutics Inc. for small molecule oncology research programs. Through this expansion the company has leveraged its offering which allowed it to penetrate its root in global medicinal chemistry for drug discovery market
• In February 2021, Eurofins acquired Beacon Discovery for its years of experience in drug discovery and development and innovative approach. Beacon Discovery is also well known for its profound expertise in GPCR (G-Protein Coupled Receptor) research. Through this acquisition the company has strengthen its presence in global medicinal chemistry for drug discovery market

Global Medicinal Chemistry for Drug Discovery Market Scope

The medicinal chemistry for drug discovery market is segmented on the process, design, drug type, therapeutic area and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Process

• Target Selection
• Target Validation
• Hit-To-Lead Identification
• Lead Optimization
• Candidate Validation

Design

• Fragment-Based Variation
• Structure-Based Drug Design
• Diversity Oriented Synthesis
• Chemogenomics
• Natural Products
• Others

Drug Type

• Small Molecules
• Biologics

Therapeutic Area

• Oncology
• Neurology
• Infectious and Immune System Diseases
• Cardiovascular Diseases
• Digestive System Diseases
• Others

End User

• Contract Research Organization
• Pharmaceuticals and Biotechnology Companies
• Academic and Research Institutes
• Others

Global Medicinal Chemistry for Drug Discovery Market Regional Analysis/Insights

The medicinal chemistry for drug discovery market is analysed and market size insights and trends are provided by country, process, design, drug type, therapeutic area and end user as referenced above.

The countries covered in the medicinal chemistry for drug discovery market report are U.S., Canada and Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, rest of Asia-Pacific, Saudi Arabia, U.A.E., South Africa, Egypt, Israel, rest of Middle East and Africa, Brazil, Argentina and rest of South America.  

North America is expected to dominate the medicinal chemistry for drug discovery market due to increasing clinical trials and research development for prevention of chronic diseases in the region.

Asia-Pacific is expected to grow at the highest growth rate during the forecast period of 2023 to 2030 due to increasing initiatives for research on rare diseases and orphan drugs in the region in the coming years.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure growth Installed base and New Technology Penetration

The medicinal chemistry for drug discovery market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for medicinal chemistry for drug discovery market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the medicinal chemistry for drug discovery market. The data is available for historic period 2010-2020.

Competitive Landscape and Global Medicinal Chemistry for Drug Discovery Market Share Analysis

Le paysage concurrentiel du marché de la chimie médicinale pour la découverte de médicaments fournit des détails par concurrent. Les détails inclus sont la présentation de l'entreprise, les finances de l'entreprise, les revenus générés, le potentiel du marché, les investissements dans la recherche et le développement, les nouvelles initiatives du marché, la présence mondiale, les sites et installations de production, les capacités de production, les forces et les faiblesses de l'entreprise, le lancement du produit, la largeur et l'étendue du produit, la domination des applications. Les points de données ci-dessus fournis ne concernent que l'orientation des entreprises liée au marché de la chimie médicinale pour la découverte de médicaments.

Certains des principaux acteurs opérant sur le marché de la chimie médicinale pour la découverte de médicaments sont :

• Eurofins Scientific (Allemagne)
• Covance Inc. (États-Unis)
• WuXi AppTec (Chine)
• Thermo Fisher Scientific, Inc. (États-Unis)
• Evotec SE (Allemagne)
• Piramal Pharma Solutions (Inde)
• Pfizer, Inc. (États-Unis)
• Certara (États-Unis)
• Sygnature Discovery Limited (Royaume-Uni)
• Malvern Panalytical Ltd (Royaume-Uni)
• Jubilant Biosys Ltd. (Inde)
• Taros Chemicals GmbH & Co. KG (Allemagne)
• GenScript Biotech Corporation (États-Unis)
• Nereid Therapeutics Inc. (États-Unis)
• BioBlocks, Inc. (États-Unis)
• Charnwood Molecular LTD (Royaume-Uni)
• Domainex (Royaume-Uni)
• Aurigene Pharmaceutical Services Ltd. (une filiale de Dr. Reddy's Laboratories Ltd.) (Inde)
• Selvita (États-Unis)
• Nanosyn (États-Unis)

SKU-34864